Pinar Iyidogan, Ph.D.
Affiliations: | Chemistry | Emory University, Atlanta, GA |
Area:
Protein EngineeringGoogle:
"Pinar Iyidogan"Mean distance: 8.77
Parents
Sign in to add mentor| Stefan Lutz | grad student | 2008 | Emory | |
| (Engineering the substrate specificity of human deoxycytidine kinase.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Langdon CG, Platt JT, Means RE, et al. (2017) Combinatorial screening of pancreatic adenocarcinoma reveals sensitivity to drug combinations including bromodomain inhibitor plus neddylation inhibitor. Molecular Cancer Therapeutics |
| Langdon CG, Wiedemann N, Held MA, et al. (2015) SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells. Oncotarget |
| Mukerjee A, Iyidogan P, Castellanos-Gonzalez A, et al. (2015) A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium. Bioorganic & Medicinal Chemistry Letters. 25: 2065-7 |
| Langdon CG, Held MA, Platt JT, et al. (2015) The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors. Pigment Cell & Melanoma Research. 28: 417-30 |
| Langdon CG, Wiedemann N, Held MA, et al. (2015) Abstract 2529: Debio 1143 synergizes with taxanes, topoisomerase and bromodomain inhibitors to inhibit growth of lung adenocarcinoma Cancer Research. 75: 2529-2529 |
| Iyidogan P, Anderson KS. (2014) Current perspectives on HIV-1 antiretroviral drug resistance. Viruses. 6: 4095-139 |
| Iyidogan P, Anderson KS. (2014) Recent findings on the mechanisms involved in tenofovir resistance. Antiviral Chemistry & Chemotherapy. 23: 217-22 |
| Iyidogan P, Sullivan TJ, Chordia MD, et al. (2013) Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase. Acs Medicinal Chemistry Letters. 4: 1183-8 |
| Bailey CM, Sullivan TJ, Iyidogan P, et al. (2013) Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy. Journal of Medicinal Chemistry. 56: 3959-68 |
| Piao D, Basavapathruni A, Iyidogan P, et al. (2013) Bifunctional inhibition of HIV-1 reverse transcriptase: a first step in designing a bifunctional triphosphate. Bioorganic & Medicinal Chemistry Letters. 23: 1511-8 |